Summary
Updated Aug 31, 2026
Leah R. Neufeld is CHIEF PEOPLE OFFICER of Immuneering Corp (IMRX). 6 SEC Form 4 filings on record going back to 2025, most recently on 17 March 2026. Most recent open-market trade: bought $11K of IMRX on 15 January 2026. Lifetime open-market purchases: $19K. Historical track record: 3/5 stars across 3 tracked purchases.
Recent Transactions
5Every recent SEC Form 4 transaction Leah R. Neufeld has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★☆☆ (3/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 67% |
| 90-day win rate | 100% |
| Avg 5-day return | +9.05% |
| Avg 30-day return | +7.28% |
| Avg 90-day return | +46.22% |
| Best 30-day return | +19.95% |
Trading Pattern
InsiderAlpha's records for Leah R. Neufeld go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. The typical open-market purchase is $6K (3 buys totaling $19K). The largest single buy on record is $11K of IMRX in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Leah R. Neufeld files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter Feinberg - $226K of IMRX open-market activity in the last 12 months
- Thomas J. Schall - $101K of IMRX open-market activity in the last 12 months
- Brett Matthew Hall - $36K of IMRX open-market activity in the last 12 months
- Harold Eugene Brakewood - $25K of IMRX open-market activity in the last 12 months
- Benjamin J. Zeskind - $11K of IMRX open-market activity in the last 12 months
- Michael Bookman - $7K of IMRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Leah R. Neufeld?
Leah R. Neufeld is a corporate insider, tracked as CHIEF PEOPLE OFFICER of Immuneering Corp (IMRX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Leah R. Neufeld last file a Form 4?
The most recent primary Form 4 on record is dated 17 March 2026, one of 6 filings going back to 2025.
Has Leah R. Neufeld been buying or selling stock?
Recorded transactions: 3 open-market purchases ($19K) and 0 open-market sales across all tracked filings.
How accurate is Leah R. Neufeld's historical track record?
Across 3 tracked purchases, Leah R. Neufeld averaged +7.3% avg 30-day return with a 67% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.
Where can I see all of Leah R. Neufeld's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Leah R. Neufeld and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial